nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—Conjunctival hyperaemia—Prednisolone—psoriatic arthritis	0.0364	0.0364	CcSEcCtD
Thiabendazole—Conjunctival hyperaemia—Betamethasone—psoriatic arthritis	0.0304	0.0304	CcSEcCtD
Thiabendazole—Conjunctival hyperaemia—Dexamethasone—psoriatic arthritis	0.0304	0.0304	CcSEcCtD
Thiabendazole—Jaundice—Auranofin—psoriatic arthritis	0.0274	0.0274	CcSEcCtD
Thiabendazole—Haematuria—Auranofin—psoriatic arthritis	0.0268	0.0268	CcSEcCtD
Thiabendazole—Visual impairment—Auranofin—psoriatic arthritis	0.0243	0.0243	CcSEcCtD
Thiabendazole—Visual acuity reduced—Betamethasone—psoriatic arthritis	0.0225	0.0225	CcSEcCtD
Thiabendazole—Visual acuity reduced—Dexamethasone—psoriatic arthritis	0.0225	0.0225	CcSEcCtD
Thiabendazole—Angioedema—Auranofin—psoriatic arthritis	0.0201	0.0201	CcSEcCtD
Thiabendazole—Leukopenia—Auranofin—psoriatic arthritis	0.0196	0.0196	CcSEcCtD
Thiabendazole—Anorexia—Auranofin—psoriatic arthritis	0.0171	0.0171	CcSEcCtD
Thiabendazole—Dyspepsia—Auranofin—psoriatic arthritis	0.0158	0.0158	CcSEcCtD
Thiabendazole—Decreased appetite—Auranofin—psoriatic arthritis	0.0156	0.0156	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.0146	0.0146	CcSEcCtD
Thiabendazole—Abdominal pain—Auranofin—psoriatic arthritis	0.0142	0.0142	CcSEcCtD
Thiabendazole—Pruritus—Auranofin—psoriatic arthritis	0.0127	0.0127	CcSEcCtD
Thiabendazole—Diarrhoea—Auranofin—psoriatic arthritis	0.0123	0.0123	CcSEcCtD
Thiabendazole—Vomiting—Auranofin—psoriatic arthritis	0.0114	0.0114	CcSEcCtD
Thiabendazole—Rash—Auranofin—psoriatic arthritis	0.0113	0.0113	CcSEcCtD
Thiabendazole—Dermatitis—Auranofin—psoriatic arthritis	0.0113	0.0113	CcSEcCtD
Thiabendazole—Nausea—Auranofin—psoriatic arthritis	0.0106	0.0106	CcSEcCtD
Thiabendazole—Lymphadenopathy—Methotrexate—psoriatic arthritis	0.00827	0.00827	CcSEcCtD
Thiabendazole—Hepatic failure—Methotrexate—psoriatic arthritis	0.00785	0.00785	CcSEcCtD
Thiabendazole—Visual impairment—Prednisolone—psoriatic arthritis	0.00775	0.00775	CcSEcCtD
Thiabendazole—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00756	0.00756	CcSEcCtD
Thiabendazole—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.00756	0.00756	CcSEcCtD
Thiabendazole—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00711	0.00711	CcSEcCtD
Thiabendazole—Vision blurred—Prednisolone—psoriatic arthritis	0.00659	0.00659	CcSEcCtD
Thiabendazole—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00658	0.00658	CcSEcCtD
Thiabendazole—Visual impairment—Dexamethasone—psoriatic arthritis	0.00646	0.00646	CcSEcCtD
Thiabendazole—Visual impairment—Betamethasone—psoriatic arthritis	0.00646	0.00646	CcSEcCtD
Thiabendazole—Angioedema—Prednisolone—psoriatic arthritis	0.00639	0.00639	CcSEcCtD
Thiabendazole—Convulsion—Prednisolone—psoriatic arthritis	0.00606	0.00606	CcSEcCtD
Thiabendazole—Angioedema—Triamcinolone—psoriatic arthritis	0.00588	0.00588	CcSEcCtD
Thiabendazole—Angioedema—Methylprednisolone—psoriatic arthritis	0.00587	0.00587	CcSEcCtD
Thiabendazole—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00571	0.00571	CcSEcCtD
Thiabendazole—Convulsion—Triamcinolone—psoriatic arthritis	0.00558	0.00558	CcSEcCtD
Thiabendazole—Convulsion—Methylprednisolone—psoriatic arthritis	0.00556	0.00556	CcSEcCtD
Thiabendazole—Drowsiness—Methotrexate—psoriatic arthritis	0.00544	0.00544	CcSEcCtD
Thiabendazole—Flushing—Prednisone—psoriatic arthritis	0.00542	0.00542	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00539	0.00539	CcSEcCtD
Thiabendazole—Angioedema—Betamethasone—psoriatic arthritis	0.00533	0.00533	CcSEcCtD
Thiabendazole—Angioedema—Dexamethasone—psoriatic arthritis	0.00533	0.00533	CcSEcCtD
Thiabendazole—Confusional state—Methylprednisolone—psoriatic arthritis	0.00528	0.00528	CcSEcCtD
Thiabendazole—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00525	0.00525	CcSEcCtD
Thiabendazole—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00524	0.00524	CcSEcCtD
Thiabendazole—Haematuria—Methotrexate—psoriatic arthritis	0.00518	0.00518	CcSEcCtD
Thiabendazole—Convulsion—Dexamethasone—psoriatic arthritis	0.00506	0.00506	CcSEcCtD
Thiabendazole—Convulsion—Betamethasone—psoriatic arthritis	0.00506	0.00506	CcSEcCtD
Thiabendazole—Hypotension—Methylprednisolone—psoriatic arthritis	0.0049	0.0049	CcSEcCtD
Thiabendazole—Vision blurred—Prednisone—psoriatic arthritis	0.00479	0.00479	CcSEcCtD
Thiabendazole—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00477	0.00477	CcSEcCtD
Thiabendazole—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00477	0.00477	CcSEcCtD
Thiabendazole—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00471	0.00471	CcSEcCtD
Thiabendazole—Visual impairment—Methotrexate—psoriatic arthritis	0.0047	0.0047	CcSEcCtD
Thiabendazole—Angioedema—Prednisone—psoriatic arthritis	0.00465	0.00465	CcSEcCtD
Thiabendazole—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00462	0.00462	CcSEcCtD
Thiabendazole—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00462	0.00462	CcSEcCtD
Thiabendazole—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00461	0.00461	CcSEcCtD
Thiabendazole—Tinnitus—Methotrexate—psoriatic arthritis	0.00455	0.00455	CcSEcCtD
Thiabendazole—Anorexia—Betamethasone—psoriatic arthritis	0.00454	0.00454	CcSEcCtD
Thiabendazole—Anorexia—Dexamethasone—psoriatic arthritis	0.00454	0.00454	CcSEcCtD
Thiabendazole—Fatigue—Triamcinolone—psoriatic arthritis	0.00453	0.00453	CcSEcCtD
Thiabendazole—Fatigue—Methylprednisolone—psoriatic arthritis	0.00452	0.00452	CcSEcCtD
Thiabendazole—Hypotension—Dexamethasone—psoriatic arthritis	0.00445	0.00445	CcSEcCtD
Thiabendazole—Hypotension—Betamethasone—psoriatic arthritis	0.00445	0.00445	CcSEcCtD
Thiabendazole—Convulsion—Prednisone—psoriatic arthritis	0.00441	0.00441	CcSEcCtD
Thiabendazole—Chills—Methotrexate—psoriatic arthritis	0.00438	0.00438	CcSEcCtD
Thiabendazole—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00433	0.00433	CcSEcCtD
Thiabendazole—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00432	0.00432	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00428	0.00428	CcSEcCtD
Thiabendazole—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Thiabendazole—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00419	0.00419	CcSEcCtD
Thiabendazole—Dyspepsia—Betamethasone—psoriatic arthritis	0.00419	0.00419	CcSEcCtD
Thiabendazole—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00415	0.00415	CcSEcCtD
Thiabendazole—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00414	0.00414	CcSEcCtD
Thiabendazole—Decreased appetite—Betamethasone—psoriatic arthritis	0.00414	0.00414	CcSEcCtD
Thiabendazole—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00414	0.00414	CcSEcCtD
Thiabendazole—Fatigue—Betamethasone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Thiabendazole—Fatigue—Dexamethasone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Thiabendazole—Vision blurred—Methotrexate—psoriatic arthritis	0.004	0.004	CcSEcCtD
Thiabendazole—Anorexia—Prednisone—psoriatic arthritis	0.00396	0.00396	CcSEcCtD
Thiabendazole—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00393	0.00393	CcSEcCtD
Thiabendazole—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00393	0.00393	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.0039	0.0039	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.0039	0.0039	CcSEcCtD
Thiabendazole—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00387	0.00387	CcSEcCtD
Thiabendazole—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00386	0.00386	CcSEcCtD
Thiabendazole—Leukopenia—Methotrexate—psoriatic arthritis	0.0038	0.0038	CcSEcCtD
Thiabendazole—Dizziness—Prednisolone—psoriatic arthritis	0.00378	0.00378	CcSEcCtD
Thiabendazole—Asthenia—Triamcinolone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Thiabendazole—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Thiabendazole—Abdominal pain—Betamethasone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Thiabendazole—Asthenia—Methylprednisolone—psoriatic arthritis	0.00376	0.00376	CcSEcCtD
Thiabendazole—Pruritus—Triamcinolone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Thiabendazole—Pruritus—Methylprednisolone—psoriatic arthritis	0.00371	0.00371	CcSEcCtD
Thiabendazole—Convulsion—Methotrexate—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Thiabendazole—Dyspepsia—Prednisone—psoriatic arthritis	0.00365	0.00365	CcSEcCtD
Thiabendazole—Decreased appetite—Prednisone—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Thiabendazole—Rash—Prednisolone—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Thiabendazole—Dermatitis—Prednisolone—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Thiabendazole—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Thiabendazole—Fatigue—Prednisone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Thiabendazole—Headache—Prednisolone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Thiabendazole—Confusional state—Methotrexate—psoriatic arthritis	0.0035	0.0035	CcSEcCtD
Thiabendazole—Dizziness—Triamcinolone—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Thiabendazole—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Thiabendazole—Dizziness—Methylprednisolone—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Thiabendazole—Feeling abnormal—Prednisone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Thiabendazole—Asthenia—Dexamethasone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Thiabendazole—Asthenia—Betamethasone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00339	0.00339	CcSEcCtD
Thiabendazole—Nausea—Prednisolone—psoriatic arthritis	0.00339	0.00339	CcSEcCtD
Thiabendazole—Pruritus—Dexamethasone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Thiabendazole—Pruritus—Betamethasone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Thiabendazole—Vomiting—Triamcinolone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Thiabendazole—Vomiting—Methylprednisolone—psoriatic arthritis	0.00333	0.00333	CcSEcCtD
Thiabendazole—Rash—Triamcinolone—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Thiabendazole—Dermatitis—Triamcinolone—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Thiabendazole—Anorexia—Methotrexate—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Thiabendazole—Rash—Methylprednisolone—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Thiabendazole—Dermatitis—Methylprednisolone—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Thiabendazole—Headache—Triamcinolone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Thiabendazole—Headache—Methylprednisolone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Thiabendazole—Abdominal pain—Prednisone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Thiabendazole—Diarrhoea—Betamethasone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Thiabendazole—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Thiabendazole—Hypotension—Methotrexate—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Thiabendazole—Dizziness—Dexamethasone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Thiabendazole—Dizziness—Betamethasone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Thiabendazole—Nausea—Triamcinolone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Thiabendazole—Nausea—Methylprednisolone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Thiabendazole—Somnolence—Methotrexate—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Thiabendazole—Hypersensitivity—Prednisone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Thiabendazole—Dyspepsia—Methotrexate—psoriatic arthritis	0.00305	0.00305	CcSEcCtD
Thiabendazole—Vomiting—Betamethasone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Thiabendazole—Vomiting—Dexamethasone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Thiabendazole—Decreased appetite—Methotrexate—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Thiabendazole—Rash—Betamethasone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Thiabendazole—Rash—Dexamethasone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Thiabendazole—Dermatitis—Betamethasone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Thiabendazole—Dermatitis—Dexamethasone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Thiabendazole—Fatigue—Methotrexate—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Thiabendazole—Headache—Betamethasone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Thiabendazole—Headache—Dexamethasone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Thiabendazole—Asthenia—Prednisone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Thiabendazole—Pruritus—Prednisone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Thiabendazole—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Thiabendazole—Diarrhoea—Prednisone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Thiabendazole—Nausea—Dexamethasone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Thiabendazole—Nausea—Betamethasone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Thiabendazole—Dizziness—Prednisone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Thiabendazole—Abdominal pain—Methotrexate—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Thiabendazole—Vomiting—Prednisone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Thiabendazole—Rash—Prednisone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Thiabendazole—Dermatitis—Prednisone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Thiabendazole—Headache—Prednisone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Thiabendazole—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Thiabendazole—Asthenia—Methotrexate—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Thiabendazole—Nausea—Prednisone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Thiabendazole—Pruritus—Methotrexate—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Thiabendazole—Diarrhoea—Methotrexate—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Thiabendazole—Dizziness—Methotrexate—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Thiabendazole—Vomiting—Methotrexate—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Thiabendazole—Rash—Methotrexate—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Thiabendazole—Dermatitis—Methotrexate—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Thiabendazole—Headache—Methotrexate—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Thiabendazole—Nausea—Methotrexate—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
